Earlier analyses by some of the authors of the study reported herein estimated the cost of manufacturing certain diabetes medicines, including insulins,12,13,14 finding that estimated cost-based prices were far below the market prices for insulin analogues at the time. Here, INS is linked to diabetes mellitus.